GlassScriptPhysician profile
Henry P Gottsch
NPI 1831209253
$4,464.55
in general payments reported to CMS, 2019-2025
36 companies · $806 in 2025
The $806 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $373 · 2021: $583 · 2022: $753 · 2023: $833 · 2024: $714 · 2025: $806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,248 · Education: $99.00 · Travel and Lodging: $6.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,248.21 |
| Education | $99.00 |
| Travel and Lodging | $6.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $608.54 | 2022-2024 | Provenge |
| Astellas Pharma US INC | $580.36 | 2019-2025 | Padcev, Xtandi |
| Janssen Biotech, INC. | $467.59 | 2019-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $381.61 | 2023-2025 | Orgovyx |
| Pfizer INC. | $338.19 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $211.95 | 2019-2025 | |
| Boston Scientific Corporation | $199.03 | 2019-2025 | Lithovue, Spaceoar Vue System - 10ml |
| Merck Sharp & Dohme LLC | $166.00 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Coloplast Corp | $157.66 | 2019-2025 | Supris |
| Myovant Sciences INC. | $157.18 | 2021-2022 | |
| Axonics, INC. | $145.73 | 2020-2024 | Axonics, Bulkamid |
| Abbvie INC. | $126.17 | 2020-2024 | |
| Novartis Pharmaceuticals Corporation | $112.67 | 2020-2025 | |
| Endo Pharmaceuticals INC. | $98.90 | 2021-2023 | Xiaflex, Aveed, Edex |
| Teleflex LLC | $76.74 | 2024-2025 | Barrigel, Urolift |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $62.14 | 2024-2025 | Aquabeam System |
| 180 Medical, INC. | $61.48 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $54.41 | 2019-2022 | |
| Intuitive Surgical, INC. | $45.09 | 2019-2025 | |
| Rochester Medical Corporation | $42.97 | 2020-2022 | |
| Palette Life Sciences, INC. | $42.09 | 2021-2022 | |
| Calyxo, INC. | $41.81 | 2025 | Cvac Aspiration System |
| Accord Healthcare, INC. | $35.05 | 2023 | |
| Medtronic USA, INC. | $33.95 | 2019 | |
| Ambu INC. | $27.79 | 2020-2022 | |
| Immunitybio, INC. | $24.42 | 2025 | |
| Urogen Pharma, INC. | $23.81 | 2025 | |
| Tolmar, INC. | $23.77 | 2023 | |
| Dornier Medtech America, INC | $18.28 | 2020 | |
| Olympus America INC. | $16.85 | 2020 | |
| Cook Medical LLC | $16.22 | 2024 | Cook |
| Amgen INC. | $15.27 | 2019 | |
| Angiodynamics, INC. | $14.41 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.38 | 2020 | |
| Profound Medical Corp. | $12.11 | 2022 | |
| Allergan, INC. | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Gottsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.